NanoViricides Inc. (NNVC)

[crashco]

Look back at calendar 2012. A steady output of progressive reports. Subtle but important distinctions communicated at a healthy pace, the result of low cost experiment.
Science history in review appears as dramatic as a thunderstorm with flashes of brilliance and explosive reports. Science in real time, in the present, is plodding. Progress comes only after sweat and toil, trial and error, blind alleys and far more failure then success in balance. A nascent pipeline targeting a broad range of virus has been narrowed and honed for a final push against a single illness. The market size for a flu "cure" is substantial and the illness, common and understood by the public, will open doors and funding for still larger markets.
For stockholders invested 6-7 years...you must feel the acceleration.